• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes Nitrotoluenes

Recent Advances in the Study of 2,4-Dinitro-6-methoxytoluene (CAS: 95192-65-7): A Comprehensive Research Brief

2,4-Dinitro-6-methoxytoluene (CAS: 95192-65-7) is a nitroaromatic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications. Recent studies have explored its synthesis, reactivity, and biological activities, shedding light on its potential as a building block for more complex molecules or as an active pharmaceutical ingredient (API). This research brief aims to summarize the latest findings related to this compound, providing a comprehensive overview of its current status in scientific research.

One of the key areas of interest in recent studies has been the synthesis and optimization of 2,4-Dinitro-6-methoxytoluene. Researchers have developed novel synthetic routes to improve yield and purity, which are critical for its application in pharmaceutical development. For instance, a 2023 study published in the Journal of Organic Chemistry demonstrated a high-yield, environmentally friendly synthesis method using catalytic hydrogenation, which significantly reduced the formation of by-products. This advancement is particularly relevant for scaling up production while adhering to green chemistry principles.

In addition to its synthetic applications, 2,4-Dinitro-6-methoxytoluene has been investigated for its biological activities. Preliminary studies suggest that this compound exhibits moderate antimicrobial properties against certain Gram-positive bacteria, as reported in a 2022 paper in Bioorganic & Medicinal Chemistry Letters. The mechanism of action appears to involve interference with bacterial cell wall synthesis, although further studies are needed to confirm this hypothesis. These findings open up possibilities for its use in developing new antimicrobial agents, especially in the face of rising antibiotic resistance.

Another promising avenue of research involves the derivatization of 2,4-Dinitro-6-methoxytoluene to enhance its pharmacological properties. A recent study in European Journal of Medicinal Chemistry (2023) explored the synthesis of various derivatives and their evaluation as potential anticancer agents. The results indicated that certain derivatives exhibited selective cytotoxicity against cancer cell lines, with minimal effects on normal cells. This selectivity is a crucial factor in the development of safer chemotherapeutic agents, and further optimization of these derivatives is currently underway.

Despite these promising developments, challenges remain in the widespread application of 2,4-Dinitro-6-methoxytoluene. Issues such as its stability under physiological conditions and potential toxicity profiles need to be addressed through rigorous preclinical studies. Recent toxicological assessments, as detailed in a 2023 report in Chemical Research in Toxicology, have provided initial insights into its safety profile, but comprehensive in vivo studies are still required to fully understand its pharmacokinetics and pharmacodynamics.

In conclusion, 2,4-Dinitro-6-methoxytoluene (CAS: 95192-65-7) represents a compound of growing interest in chemical biology and pharmaceutical research. Its versatile synthetic applications, coupled with emerging biological activities, make it a valuable candidate for further investigation. Future research should focus on optimizing its properties, elucidating its mechanisms of action, and evaluating its potential in therapeutic applications. As the scientific community continues to explore this compound, it is expected to play an increasingly important role in the development of novel pharmaceuticals and bioactive molecules.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)